The Time Could Be Right For This Biotech ETF


Biotechnology stocks and exchange traded funds have been slumping since last week's midterm elections and that could be an ominous sign. On Monday, the S&P Biotechnology Select Industry Index fell 3.59 percent on volume that was well above the daily average, extending what are becoming significant monthly and quarterly losses.



from Biotech News